{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:35:40Z","timestamp":1786988140727,"version":"build-2736575974"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T00:00:00Z","timestamp":1792972800000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K28015"],"award-info":[{"award-number":["JP23K28015"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19K07120"],"award-info":[{"award-number":["JP19K07120"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejphar.2025.178301","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:55:58Z","timestamp":1761353758000},"page":"178301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["L-type voltage-dependent calcium channels in the ventromedial orbitofrontal and prefrontal cortices mediate the inhibitory effects of (S)-ketamine but not (R)-ketamine on marble burying in male mice"],"prefix":"10.1016","volume":"1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5502-9746","authenticated-orcid":false,"given":"Satoshi","family":"Deyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5071-7574","authenticated-orcid":false,"given":"Kenji","family":"Mishiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3296-490X","authenticated-orcid":false,"given":"Munetaka","family":"Kunishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7046-9275","authenticated-orcid":false,"given":"Katsuyuki","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178301_bib1","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/da.22367","article-title":"Dissecting OCD circuits: from animal models to targeted treatments","volume":"32","author":"Ahmari","year":"2015","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.ejphar.2025.178301_bib2","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1126\/science.1234733","article-title":"Repeated cortico-striatal stimulation generates persistent OCD-like behavior","volume":"340","author":"Ahmari","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2025.178301_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/WNF.0000000000000578","article-title":"Esketamine augmentation in treatment-resistant obsessive-compulsive disorder: a retrospective chart review","volume":"47","author":"Alves-Pereira","year":"2024","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2025.178301_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113676","article-title":"The antidepressant effect of resolvin E1 in repeated prednisolone-induced depression model mice","volume":"418","author":"Aoki","year":"2022","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2025.178301_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbscr.2022.100082","article-title":"Shift work-like patterns effect on female and male mouse behavior","volume":"13","author":"Banks","year":"2022","journal-title":"Neurobiol. Sleep. Circadian. Rhythms."},{"key":"10.1016\/j.ejphar.2025.178301_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.668304","article-title":"Lower ventromedial prefrontal cortex glutamate levels in patients with obsessive-compulsive disorder","volume":"12","author":"Batistuzzo","year":"2021","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.ejphar.2025.178301_bib7","article-title":"Ketamine for treatment-resistant obsessive-compulsive disorder: double-blind active-controlled crossover study","author":"Beaglehole","year":"2024","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2025.178301_bib8","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1038\/npp.2009.77","article-title":"Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder","volume":"34","author":"Bhattacharyya","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2025.178301_bib9","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.biopsych.2012.05.028","article-title":"Effects of ketamine in treatment-refractory obsessive-compulsive disorder","volume":"72","author":"Bloch","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2025.178301_bib10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/0897190014521996","article-title":"Obsessive-compulsive disorder","volume":"27","author":"Bokor","year":"2014","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.ejphar.2025.178301_bib11","doi-asserted-by":"crossref","unstructured":"Bradfield, L.A., Hart, G., Balleine, B.W., Inferring action-dependent outcome representations depends on anterior but not posterior medial orbitofrontal cortex. Neurobiol. Learn. Mem. 155, 463-473. 2018. https:\/\/doi.org\/10.1016\/j.nlm.2018.09.008.","DOI":"10.1016\/j.nlm.2018.09.008"},{"key":"10.1016\/j.ejphar.2025.178301_bib12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archpsyc.1996.01830070041008","article-title":"Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder","volume":"53","author":"Breiter","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2025.178301_bib13","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.npp.1300733","article-title":"Glutamatergic dysfunction in OCD","volume":"30","author":"Chakrabarty","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2025.178301_bib14","doi-asserted-by":"crossref","first-page":"13582","DOI":"10.1523\/JNEUROSCI.0809-12.2012","article-title":"L-type voltage-gated calcium channels in the basolateral amygdala are necessary for fear extinction","volume":"32","author":"Davis","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178301_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3758\/s13415-018-00653-4","article-title":"A critical inquiry into marble-burying as a preclinical screening paradigm of relevance for anxiety and obsessive-compulsive disorder: mapping the way forward","volume":"19","author":"de Brouwer","year":"2019","journal-title":"Cognit. Affect Behav. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178301_bib16","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s13311-022-01337-1","article-title":"Intranasal administration of resolvin E1 produces antidepressant-like effects via BDNF\/VEGF-mTORC1 signaling in the medial prefrontal cortex","volume":"20","author":"Deyama","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejphar.2025.178301_bib17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jphs.2024.07.010","article-title":"Neohesperidin exerts antidepressant-like effect via the mechanistic target of rapamycin complex 1 in the medial prefrontal cortex in male mice","volume":"156","author":"Deyama","year":"2024","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2025.178301_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.biopsych.2018.12.014","article-title":"Neurotrophic and antidepressant actions of brain-derived neurotrophic factor require vascular endothelial growth factor","volume":"86","author":"Deyama","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2025.178301_bib19","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1176\/appi.ajp.2018.17121368","article-title":"Role of neuronal VEGF signaling in the prefrontal cortex in the rapid antidepressant effects of ketamine","volume":"176","author":"Deyama","year":"2019","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.ejphar.2025.178301_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172837","article-title":"Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine","volume":"188","author":"Deyama","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2025.178301_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112844","article-title":"The duration of the antidepressant-like effects of a single infusion of brain-derived neurotrophic factor into the medial prefrontal cortex in mice","volume":"394","author":"Deyama","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2025.178301_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109335","article-title":"Role of neurotrophic and growth factors in the rapid and sustained antidepressant actions of ketamine","volume":"224","author":"Deyama","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2025.178301_bib23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1248\/bpb.b24-00743","article-title":"Preventive and therapeutic effects of intracerebroventricular administration of maresin-1 on lipopolysaccharide-induced depression-like behaviors in mice","volume":"48","author":"Deyama","year":"2025","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2025.178301_bib24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41398-022-01943-9","article-title":"IGF-1 release in the medial prefrontal cortex mediates the rapid and sustained antidepressant-like actions of ketamine","volume":"12","author":"Deyama","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ejphar.2025.178301_bib25","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1080\/1028415X.2023.2254542","article-title":"Antidepressant-like effects of tomatidine and tomatine, steroidal alkaloids from unripe tomatoes, via activation of mTORC1 in the medial prefrontal cortex in lipopolysaccharide-induced depression model mice","volume":"27","author":"Deyama","year":"2024","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178301_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2020.106676","article-title":"Marble-burying behavior test as a murine model of compulsive-like behavior","volume":"102","author":"Dixit","year":"2020","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2025.178301_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(97)01116-3","article-title":"Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord","volume":"333","author":"Ebert","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178301_bib28","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"2007"},{"key":"10.1016\/j.ejphar.2025.178301_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.116.239228","article-title":"Antidepressant potential of (R)-ketamine in rodent models: comparison with (S)-ketamine","volume":"361","author":"Fukumoto","year":"2017","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2025.178301_bib30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1021\/acs.oprd.9b00436","article-title":"Lewis acid-catalyzed racemization and recycling of the undesired (R)-ketamine","volume":"24","author":"Gao","year":"2020","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.ejphar.2025.178301_bib31","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1172\/JCI130808","article-title":"GABA interneurons are the cellular trigger for ketamine's rapid antidepressant actions","volume":"130","author":"Gerhard","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2025.178301_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107947","article-title":"Ketamine increases vmPFC activity: effects of (R)- and (S)-stereoisomers and (2R,6R)-hydroxynorketamine metabolite","volume":"166","author":"Hare","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2025.178301_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adv5986","article-title":"Microglial BDNF modulates arketamine's antidepressant-like effects through cortico-accumbal pathways","volume":"11","author":"He","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejphar.2025.178301_bib34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jpsychires.2020.12.066","article-title":"Risk of specific cardiovascular diseases in obsessive-compulsive disorder","volume":"135","author":"Isomura","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ejphar.2025.178301_bib35","doi-asserted-by":"crossref","first-page":"10529","DOI":"10.1523\/JNEUROSCI.1678-17.2017","article-title":"Functional Heterogeneity within rat orbitofrontal cortex in reward learning and decision making","volume":"37","author":"Izquierdo","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178301_bib36","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/mp.2011.50","article-title":"Deficient serotonin neurotransmission and depression-like serotonin biomarker alterations in tryptophan hydroxylase 2 (Tph2) loss-of-function mice","volume":"17","author":"Jacobsen","year":"2012","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejphar.2025.178301_bib37","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.neuron.2024.01.023","article-title":"Sustained antidepressant effects of ketamine metabolite involve GABAergic inhibition-mediated molecular dynamics in aPVT glutamatergic neurons","volume":"112","author":"Kawatake-Kuno","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2025.178301_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMp1903305","article-title":"Esketamine for treatment-resistant depression - first FDA-approved antidepressant in a new class","volume":"381","author":"Kim","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.178301_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2900","article-title":"Prescribing patterns in patients with obsessive-compulsive disorder: retrospective, single-center study","volume":"39","author":"Knebel","year":"2024","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2025.178301_bib40","first-page":"371","article-title":"Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology","volume":"29","author":"Korff","year":"2006","journal-title":"Psychiatr. Clin."},{"key":"10.1016\/j.ejphar.2025.178301_bib41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.euroneuro.2020.04.007","article-title":"Similarities and dissimilarities in the effects of benzodiazepines and specific serotonin reuptake inhibitors (SSRIs) in the defensive marble burying test: a systematic review and meta-analysis","volume":"36","author":"Langer","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2025.178301_bib42","article-title":"BDNF release is required for the behavioral actions of ketamine","volume":"18","author":"Lepack","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2025.178301_bib43","article-title":"S-ketamine alleviates neuroinflammation and attenuates lipopolysaccharide-induced depression via targeting SIRT2","volume":"12","author":"Lin","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.ejphar.2025.178301_bib44","article-title":"Esketamine is approved in Europe for treating resistant major depressive disorder","volume":"367","author":"Mahase","year":"2019","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ejphar.2025.178301_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/syn.22126","article-title":"(R)- and (S)-ketamine induce differential fMRI responses in conscious rats","volume":"73","author":"Masaki","year":"2019","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2025.178301_bib46","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2025.178301_bib47","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejphar.2012.11.023","article-title":"Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in alpha7 nicotinic acetylcholine receptors","volume":"698","author":"Moaddel","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178301_bib48","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.pnpbp.2005.11.028","article-title":"Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines","volume":"30","author":"Pallanti","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2025.178301_bib49","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrn3746","article-title":"Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective","volume":"15","author":"Pauls","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178301_bib50","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.pharmthera.2011.09.006","article-title":"Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment","volume":"132","author":"Pittenger","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2025.178301_bib51","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s12640-017-9759-0","article-title":"Comparison of the psychopharmacological effects of tiletamine and ketamine in rodents","volume":"32","author":"Popik","year":"2017","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2025.178301_bib52","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1021\/acs.jmedchem.8b01810","article-title":"Discovery of an orally bioavailable and central nervous system (CNS) penetrant mGlu(7) negative allosteric modulator (NAM) in vivo tool compound: N-(2-(1H-1,2,4-triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide (VU6012962)","volume":"62","author":"Reed","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2025.178301_bib53","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1038\/npp.2013.150","article-title":"Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept","volume":"38","author":"Rodriguez","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2025.178301_bib54","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/mp.2008.94","article-title":"The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication","volume":"15","author":"Ruscio","year":"2010","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejphar.2025.178301_bib55","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/bja\/aeh144","article-title":"Chronopharmacological studies of ketamine in normal and NMDA epsilon1 receptor knockout mice","volume":"92","author":"Sato","year":"2004","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejphar.2025.178301_bib56","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1037\/bne0000456","article-title":"The stressed orbitofrontal cortex","volume":"135","author":"Sequeira","year":"2021","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178301_bib57","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nm.2125","article-title":"Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice","volume":"16","author":"Shmelkov","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2025.178301_bib58","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41398-023-02456-9","article-title":"Effect of psilocybin on marble burying in ICR mice: role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder","volume":"13","author":"Singh","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ejphar.2025.178301_bib59","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1073\/pnas.1814292116","article-title":"Basolateral amygdala input to the medial prefrontal cortex controls obsessive-compulsive disorder-like checking behavior","volume":"116","author":"Sun","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2025.178301_bib60","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1254\/jjp.90.197","article-title":"Effect of YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT 2A receptor antagonistic activity, on a marble-burying behavior test as an obsessive-compulsive disorder model","volume":"90","author":"Takeuchi","year":"2002","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178301_bib61","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00213-009-1466-y","article-title":"Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety","volume":"204","author":"Thomas","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2025.178301_bib62","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00213-019-05397-8","article-title":"Ketamine induces immediate and delayed alterations of OCD-like behavior","volume":"237","author":"Thompson","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2025.178301_bib63","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neuropharm.2018.10.039","article-title":"S-ketamine reduces marble burying behaviour: involvement of ventromedial orbitofrontal cortex and AMPA receptors","volume":"144","author":"Tosta","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2025.178301_bib64","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3389\/fneur.2018.01052","article-title":"Gastrodin rescues autistic-like phenotypes in valproinc acid-induced animal model","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejphar.2025.178301_bib65","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41380-021-01121-1","article-title":"Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor","volume":"27","author":"Wei","year":"2022","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejphar.2025.178301_bib66","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pscychresns.2005.12.006","article-title":"A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety","volume":"146","author":"Whiteside","year":"2006","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ejphar.2025.178301_bib67","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biopsych.2017.05.016","article-title":"Mechanistic target of rapamycin-independent antidepressant effects of (R)-ketamine in a social defeat stress model","volume":"83","author":"Yang","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2025.178301_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ejphar.2025.178301_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172876","article-title":"(S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression","volume":"191","author":"Yokoyama","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2025.178301_bib71","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.178301_bib72","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1038\/s41380-025-03003-2","article-title":"Cardiovascular diseases and depression: a meta-analysis and mendelian randomization analysis","volume":"30","author":"Zeng","year":"2025","journal-title":"Mol. Psychiatr."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925010556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925010556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:33:31Z","timestamp":1779323611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925010556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":71,"alternative-id":["S0014299925010556"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178301","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"L-type voltage-dependent calcium channels in the ventromedial orbitofrontal and prefrontal cortices mediate the inhibitory effects of (S)-ketamine but not (R)-ketamine on marble burying in male mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178301","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178301"}}